RHKU Stock Overview
Offers in-patient, semi-patient, and outpatient healthcare services in Germany. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for RHKU from our risk checks.
RHÖN-KLINIKUM Aktiengesellschaft Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €5.75 |
| 52 Week High | €6.35 |
| 52 Week Low | €4.54 |
| Beta | -0.11 |
| 11 Month Change | 0% |
| 3 Month Change | 5.50% |
| 1 Year Change | 9.52% |
| 33 Year Change | -22.82% |
| 5 Year Change | n/a |
| Change since IPO | -33.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| RHKU | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.3% | -1.3% |
| 1Y | 9.5% | 15.7% | 7.4% |
Return vs Industry: RHKU underperformed the German Healthcare industry which returned 14.5% over the past year.
Return vs Market: RHKU exceeded the German Market which returned 7.1% over the past year.
Price Volatility
| RHKU volatility | |
|---|---|
| RHKU Average Weekly Movement | 5.0% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: RHKU has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: RHKU's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 18,507 | Tobias Kaltenbach | www.rhoen-klinikum-ag.com |
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. It also operates acute hospitals, medical care centers, and rehabilitation hospitals. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.
RHÖN-KLINIKUM Aktiengesellschaft Fundamentals Summary
| RHKU fundamental statistics | |
|---|---|
| Market cap | €850.12m |
| Earnings (TTM) | €44.87m |
| Revenue (TTM) | €1.84b |
18.9x
P/E Ratio0.5x
P/S RatioIs RHKU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RHKU income statement (TTM) | |
|---|---|
| Revenue | €1.84b |
| Cost of Revenue | €1.62b |
| Gross Profit | €211.75m |
| Other Expenses | €166.88m |
| Earnings | €44.87m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 27, 2025
| Earnings per share (EPS) | 0.67 |
| Gross Margin | 11.54% |
| Net Profit Margin | 2.44% |
| Debt/Equity Ratio | 10.9% |
How did RHKU perform over the long term?
See historical performance and comparison